Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference

MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.29 (+0.78%)
MannKind Presents Positive Afrezza(R) Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD

MannKind Corporation (NASDAQ: MNKD) announced that data from a one-year study of Afrezza(R) (insulin human) Inhalation Powder was presented at the 55 Annual Meeting of the European Association for the...

MNKD : 1.29 (+0.78%)
United Therapeutics' Trevyent NDA for PAH Accepted by FDA

United Therapeutics (UTHR) announces acceptance of Trevyent NDA by the FDA for pulmonary arterial hypertension.

MDT : 107.90 (+0.31%)
MNKD : 1.29 (+0.78%)
ARNA : 48.39 (+2.26%)
UTHR : 81.81 (+0.69%)
MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference

MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.29 (+0.78%)
MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform

MannKind Corporation (NASDAQ: MNKD) and One Drop today announced that they have signed a collaborative agreement that is intended to integrate MannKind's BluHale(R) accessory device into the One Drop platform....

MNKD : 1.29 (+0.78%)
MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019

MannKind Corporation (NASDAQ: MNKD) will release its 2019 second quarter and year-to-date financial results and its management will host a conference call to discuss the financial results and corporate...

MNKD : 1.29 (+0.78%)
Afrezza(R) Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3

MannKind Corporation (NASDAQ:MNKD) announced today that the Afrezza safety and pharmacokinetics study in pediatric patients is now enrolling children 4-7 years of age (Cohort 3) and nearing completion...

MNKD : 1.29 (+0.78%)
MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants

MannKind Corporation (NASDAQ: MNKD) today announced the repayment of outstanding debt by an aggregate amount of approximately $4.0 million and the repurchase of a warrant to purchase approximately 3.3...

MNKD : 1.29 (+0.78%)
MannKind Expands Commercial Scale Manufacturing Capabilities for High-Potency Molecules

MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.29 (+0.78%)
MannKind Presents Positive Afrezza(R) Clinical Data from Three Studies at ADA 79th Scientific Sessions

MannKind Corporation (Nasdaq: MNKD) announced that new data from three different studies of Afrezza(R) (insulin human) Inhalation Powder were released at the American Diabetes Association's 79th Scientific...

MNKD : 1.29 (+0.78%)
MannKind Announces Afrezza(R) Distribution Agreement in Australia

MannKind Corporation (Nasdaq: MNKD) today announced that it has entered into an exclusive marketing and distribution agreement with the AMSL Diabetes division of Australasian Medical & Scientific Ltd....

MNKD : 1.29 (+0.78%)
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat

United Therapeutics (UTHR) beats estimates on both fronts in the first quarter. However, earnings and revenues decline year over year.

LLY : 109.61 (+1.58%)
MNKD : 1.29 (+0.78%)
ARNA : 48.39 (+2.26%)
UTHR : 81.81 (+0.69%)
MannKind Corporation to Hold 2019 First Quarter Financial Results Conference Call on May 7, 2019

MannKind Corporation (Nasdaq:MNKD) will release its 2019 first quarter financial results on Tuesday, May 7, 2019 and its management will host a conference call to discuss the financial results and other...

MNKD : 1.29 (+0.78%)
MannKind Presents Scientific Data at 28th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE 2019)

MannKind Corporation (Nasdaq:MNKD) today announced additional data supporting the distinct clinical profile of Afrezza will be presented in an e-poster presentation on Thursday, April 25, 2019 at the 28...

MNKD : 1.29 (+0.78%)
Detailed Research: Economic Perspectives on MannKind, Sonic Automotive, Five Prime Therapeutics, CONMED, Cohu, and FTI Consulting -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation (NASDAQ:MNKD),...

MNKD : 1.29 (+0.78%)
SAH : 28.89 (+0.14%)
FPRX : 4.12 (+0.73%)
CNMD : 95.13 (+0.50%)
COHU : 14.56 (+1.04%)
FCN : 110.44 (+1.26%)
MannKind to Present at the H.C. Wainwright Global Life Sciences Conference

MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.29 (+0.78%)
MannKind Receives $12.5 Million Milestone Payment from United Therapeutics

MannKind Corporation (NASDAQ: MNKD) today announced that it achieved the first of several specified development milestones under its licensing and collaboration agreement with United Therapeutics for the...

UTHR : 81.81 (+0.69%)
MNKD : 1.29 (+0.78%)
Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance

Veeva Systems (NYSE:VEEV) today announced that life sciences companies are adopting Veeva Nitro to accelerate their data warehouse projects and deliver faster insights to the...

VEEV : 155.95 (+1.78%)
KPTI : 10.38 (+2.67%)
MNKD : 1.29 (+0.78%)
MannKind to Sponsor Andretti Autosport Type 1 Diabetes Driver, Conor Daly

MannKind Corporation (Nasdaq:MNKD) announced today it is sponsoring Conor Daly as he makes his debut with the Andretti Autosport team at the 103rd Running of the Indianapolis 500 on May 26, 2019. MannKind...

MNKD : 1.29 (+0.78%)
MannKind Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 26, 2019 / MannKind Corporation (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 26, 2019 at 9:00 AM...

MNKD : 1.29 (+0.78%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -2.14 , AIZ +0.23 , SBAC -4.58 , SO -0.33 , WELL -0.98
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar